KR101979761B1 - Composition containing Lactobacillus plantarum HY7715 for preventing from skin damage and improving skin health against fine dust as effective component - Google Patents
Composition containing Lactobacillus plantarum HY7715 for preventing from skin damage and improving skin health against fine dust as effective component Download PDFInfo
- Publication number
- KR101979761B1 KR101979761B1 KR1020180134379A KR20180134379A KR101979761B1 KR 101979761 B1 KR101979761 B1 KR 101979761B1 KR 1020180134379 A KR1020180134379 A KR 1020180134379A KR 20180134379 A KR20180134379 A KR 20180134379A KR 101979761 B1 KR101979761 B1 KR 101979761B1
- Authority
- KR
- South Korea
- Prior art keywords
- lactobacillus plantarum
- fine dust
- preventing
- skin
- active ingredient
- Prior art date
Links
- 240000006024 Lactobacillus plantarum Species 0.000 title claims abstract description 62
- 235000013965 Lactobacillus plantarum Nutrition 0.000 title claims abstract description 61
- 229940072205 lactobacillus plantarum Drugs 0.000 title claims abstract description 61
- 239000000428 dust Substances 0.000 title claims abstract description 32
- 239000000203 mixture Substances 0.000 title claims abstract description 25
- 230000037380 skin damage Effects 0.000 title claims abstract description 12
- 230000036559 skin health Effects 0.000 title 1
- 230000014509 gene expression Effects 0.000 claims abstract description 27
- 102100031476 Cytochrome P450 1A1 Human genes 0.000 claims abstract description 23
- 101710104049 Cytochrome P450 1A1 Proteins 0.000 claims abstract description 23
- 239000004480 active ingredient Substances 0.000 claims abstract description 22
- 102000003984 Aryl Hydrocarbon Receptors Human genes 0.000 claims abstract description 20
- 108090000448 Aryl Hydrocarbon Receptors Proteins 0.000 claims abstract description 20
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 13
- 230000000694 effects Effects 0.000 claims abstract description 11
- 235000015140 cultured milk Nutrition 0.000 claims abstract description 8
- 239000002537 cosmetic Substances 0.000 claims abstract description 7
- 235000020510 functional beverage Nutrition 0.000 claims abstract description 7
- 230000036541 health Effects 0.000 claims abstract description 7
- 235000013305 food Nutrition 0.000 claims abstract description 6
- 235000013376 functional food Nutrition 0.000 claims abstract description 6
- 210000003491 skin Anatomy 0.000 claims description 16
- 230000006378 damage Effects 0.000 claims description 11
- 239000006071 cream Substances 0.000 claims description 8
- 235000016709 nutrition Nutrition 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 6
- 210000004927 skin cell Anatomy 0.000 claims description 6
- 230000003247 decreasing effect Effects 0.000 claims description 4
- 239000006210 lotion Substances 0.000 claims description 4
- 238000009472 formulation Methods 0.000 claims description 3
- 125000005575 polycyclic aromatic hydrocarbon group Chemical group 0.000 abstract description 7
- 210000002510 keratinocyte Anatomy 0.000 description 26
- 210000004027 cell Anatomy 0.000 description 21
- 241000894006 Bacteria Species 0.000 description 18
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 16
- 239000002609 medium Substances 0.000 description 16
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 15
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 12
- 238000012360 testing method Methods 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 239000008176 lyophilized powder Substances 0.000 description 9
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 8
- 241000186660 Lactobacillus Species 0.000 description 8
- 239000004310 lactic acid Substances 0.000 description 8
- 235000014655 lactic acid Nutrition 0.000 description 8
- 229940039696 lactobacillus Drugs 0.000 description 8
- 239000008213 purified water Substances 0.000 description 8
- 239000012091 fetal bovine serum Substances 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 235000011187 glycerol Nutrition 0.000 description 6
- 208000019061 glycogen storage disease due to GLUT2 deficiency Diseases 0.000 description 6
- 239000006166 lysate Substances 0.000 description 6
- 239000013642 negative control Substances 0.000 description 6
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 6
- 239000006188 syrup Substances 0.000 description 6
- 235000020357 syrup Nutrition 0.000 description 6
- 108020004465 16S ribosomal RNA Proteins 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 239000013641 positive control Substances 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 239000006041 probiotic Substances 0.000 description 5
- 235000018291 probiotics Nutrition 0.000 description 5
- 239000001993 wax Substances 0.000 description 5
- 229920001817 Agar Polymers 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- 230000003833 cell viability Effects 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- 239000000049 pigment Substances 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 3
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 3
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 3
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical class NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 3
- 229920001214 Polysorbate 60 Polymers 0.000 description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000010419 fine particle Substances 0.000 description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 229940057995 liquid paraffin Drugs 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 3
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 3
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 3
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 3
- 229940113124 polysorbate 60 Drugs 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 239000012925 reference material Substances 0.000 description 3
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 3
- 229940032094 squalane Drugs 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 3
- DXBHBZVCASKNBY-UHFFFAOYSA-N 1,2-Benz(a)anthracene Chemical compound C1=CC=C2C3=CC4=CC=CC=C4C=C3C=CC2=C1 DXBHBZVCASKNBY-UHFFFAOYSA-N 0.000 description 2
- 101150104892 AHR gene Proteins 0.000 description 2
- FMMWHPNWAFZXNH-UHFFFAOYSA-N Benz[a]pyrene Chemical compound C1=C2C3=CC=CC=C3C=C(C=C3)C2=C2C3=CC=CC2=C1 FMMWHPNWAFZXNH-UHFFFAOYSA-N 0.000 description 2
- KHNYNFUTFKJLDD-UHFFFAOYSA-N Benzo[j]fluoranthene Chemical compound C1=CC(C=2C3=CC=CC=C3C=CC=22)=C3C2=CC=CC3=C1 KHNYNFUTFKJLDD-UHFFFAOYSA-N 0.000 description 2
- HAXBIWFMXWRORI-UHFFFAOYSA-N Benzo[k]fluoranthene Chemical compound C1=CC(C2=CC3=CC=CC=C3C=C22)=C3C2=CC=CC3=C1 HAXBIWFMXWRORI-UHFFFAOYSA-N 0.000 description 2
- 241000186000 Bifidobacterium Species 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- 241000194020 Streptococcus thermophilus Species 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 230000006907 apoptotic process Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- FTOVXSOBNPWTSH-UHFFFAOYSA-N benzo[b]fluoranthene Chemical compound C12=CC=CC=C1C1=CC3=CC=CC=C3C3=C1C2=CC=C3 FTOVXSOBNPWTSH-UHFFFAOYSA-N 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 235000008504 concentrate Nutrition 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 101150055214 cyp1a1 gene Proteins 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 150000002168 ethanoic acid esters Chemical class 0.000 description 2
- 235000021107 fermented food Nutrition 0.000 description 2
- 235000021022 fresh fruits Nutrition 0.000 description 2
- 235000015203 fruit juice Nutrition 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000007902 hard capsule Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 235000021579 juice concentrates Nutrition 0.000 description 2
- 235000021109 kimchi Nutrition 0.000 description 2
- 235000005152 nicotinamide Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- BBEAQIROQSPTKN-UHFFFAOYSA-N pyrene Chemical compound C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C43 BBEAQIROQSPTKN-UHFFFAOYSA-N 0.000 description 2
- 238000003753 real-time PCR Methods 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- MKNQNPYGAQGARI-UHFFFAOYSA-N 4-(bromomethyl)phenol Chemical compound OC1=CC=C(CBr)C=C1 MKNQNPYGAQGARI-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 description 1
- 241000186016 Bifidobacterium bifidum Species 0.000 description 1
- 241001608472 Bifidobacterium longum Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 102100035882 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 241000194033 Enterococcus Species 0.000 description 1
- 241000194032 Enterococcus faecalis Species 0.000 description 1
- 241000194031 Enterococcus faecium Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 1
- 238000003794 Gram staining Methods 0.000 description 1
- 240000001046 Lactobacillus acidophilus Species 0.000 description 1
- 240000001929 Lactobacillus brevis Species 0.000 description 1
- 244000199866 Lactobacillus casei Species 0.000 description 1
- 241000186673 Lactobacillus delbrueckii Species 0.000 description 1
- 241000186840 Lactobacillus fermentum Species 0.000 description 1
- 241000186606 Lactobacillus gasseri Species 0.000 description 1
- 240000002605 Lactobacillus helveticus Species 0.000 description 1
- 241000186605 Lactobacillus paracasei Species 0.000 description 1
- 241000186604 Lactobacillus reuteri Species 0.000 description 1
- 241000218588 Lactobacillus rhamnosus Species 0.000 description 1
- 241000186869 Lactobacillus salivarius Species 0.000 description 1
- 241000194036 Lactococcus Species 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 238000010802 RNA extraction kit Methods 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 244000057717 Streptococcus lactis Species 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- ABIUHPWEYMSGSR-UHFFFAOYSA-N bromocresol purple Chemical compound BrC1=C(O)C(C)=CC(C2(C3=CC=CC=C3S(=O)(=O)O2)C=2C=C(Br)C(O)=C(C)C=2)=C1 ABIUHPWEYMSGSR-UHFFFAOYSA-N 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 238000010609 cell counting kit-8 assay Methods 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000010779 crude oil Substances 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- LHRCREOYAASXPZ-UHFFFAOYSA-N dibenz[a,h]anthracene Chemical compound C1=CC=C2C(C=C3C=CC=4C(C3=C3)=CC=CC=4)=C3C=CC2=C1 LHRCREOYAASXPZ-UHFFFAOYSA-N 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- GVEPBJHOBDJJJI-UHFFFAOYSA-N fluoranthrene Natural products C1=CC(C2=CC=CC=C22)=C3C2=CC=CC3=C1 GVEPBJHOBDJJJI-UHFFFAOYSA-N 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 230000007366 host health Effects 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 235000020191 long-life milk Nutrition 0.000 description 1
- 239000012139 lysis buffer Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- CJRQAPHWCGEATR-UHFFFAOYSA-N n-methyl-n-prop-2-ynylbutan-2-amine Chemical compound CCC(C)N(C)CC#C CJRQAPHWCGEATR-UHFFFAOYSA-N 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019449 other food additives Nutrition 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 235000021110 pickles Nutrition 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 235000008476 powdered milk Nutrition 0.000 description 1
- 230000000529 probiotic effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000009993 protective function Effects 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000037373 wrinkle formation Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/169—Plantarum
-
- A23Y2220/67—
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
본 발명은 락토바실러스 플란타룸(Lactobacillus plantarum) HY7715를 유효성분으로 함유하는 미세먼지에 의한 피부의 손상 방지 및 개선을 위한 조성물에 관한 것으로서, 보다 상세하게는 사람의 피부세포에서 AhR(Aryl hydrocarbon receptor) 및 CYP1A1(Cytochrome P450 1A1) 유전자의 발현을 감소시킴으로써 미세먼지에 의한 피부의 손상을 방지 및 개선하는 효능을 갖는 락토바실러스 플란타룸(Lactobacillus plantarum) HY7715을 유효성분으로 함유하는 미세먼지에 의한 피부의 손상 방지 및 개선을 위한 조성물에 관한 것이다.The present invention relates to a composition for preventing and improving damage to skin caused by fine dust containing Lactobacillus plantarum HY7715 as an active ingredient. More particularly, the present invention relates to a composition for preventing and / ) And CYP1A1 (Cytochrome P450 1A1) genes, thereby preventing and improving damage to the skin caused by fine dusts. The present invention relates to a method for treating skin caused by fine dusts containing Lactobacillus plantarum HY7715 as an active ingredient, And more particularly to a composition for preventing and improving the damage of the skin.
미세먼지란 눈에 보이지 않을 만큼 매우 작은 대기 중에 떠다니는 먼지로 공기역학적 지름이 50μm 이하인 총 먼지(TSP, total suspended particle) 중에서 10μm 보다 작은 먼지로 정의한다. 세부적으로 지름이 10μm 보다 작은 미세먼지(PM10)와 지금이 2.5μm 보다 작은 초미세먼지(PM2.5)로 나뉜다. 미세먼지는 입자의 크기가 피부의 모공의 5분의 1정도로 작기 때문에 미세먼지가 피부 안으로 침투하면 피부 바깥층의 보호막 기능이 손상되고 자극에 대해 민감해진다. 이는 피부 장벽 기능 저하 및 탄력 저하, 여드름으로 이어질 수 있다. 특히, 미세먼지 속 다환방향족 탄화수소(polyaromatic hydrocarbons)는 피부 모낭을 통하여 피부 속으로 들어와 멜라닌 세포와 색소반점을 증가시키며, 콜라겐 합성 감소와 분해를 증가시켜 주름 생성 및 탄력을 저하시켜 피부와 노화를 촉진한다.Fine dust is defined as dust that is floating in the air that is too small to be seen, less than 10 μm of total suspended particles (TSP) with an aerodynamic diameter of 50 μm or less. It is divided into fine dust (PM10) with diameter smaller than 10μm and ultra fine dust (PM2.5) with smaller diameter than 2.5μm. Since fine particles are small in size by about one-fifth of the pores of the skin, penetration of fine dust into the skin damages the protective function of the skin's outer layer and makes it susceptible to irritation. This can lead to skin barrier function deterioration, reduced elasticity, and acne. In particular, polyaromatic hydrocarbons in fine dusts enter the skin through skin follicles to increase melanocyte and pigment spots, increase collagen synthesis and degradation, and reduce wrinkle formation and elasticity to promote skin and aging do.
프로바이오틱스(Probiotics)는 2002년 FAO(Food and Agriculture Organization of the United Nations)와 WHO(World Health Organization)에 의해 충분한 양을 섭취하였을 때 숙주의 건강에 도움을 주는 살아있는 미생물로 정의된다. 현재 식약처에서 고시형으로 등재한 프로바이오틱스는 총 19종으로 락토바실러스(Lactobacillus) 11종(L. acidophilus, L. casei, L. gasseri, L. delbruekii subsp. bulgaricus, L. helveticus, L. fermentum, L. paracasei, L. plantarum, L. reuteri, L. rhamnosus, L. salivarius)과 락토코커스(Lactococcus) 1종(Lc. lactis), 엔테로코커스(Enterococcus) 2종(E. faecium, E. faecalis), 스트렙토코커스(Streptococcus) 1종(S. thermophilus), 비피도박테리움(Bifidobacterium) 4종(B. bifidum, B. breve, B. longum, B. animalis subsp. lactis)이 있다. Probiotics are defined as live microorganisms that help the host's health when consumed in sufficient quantities by the Food and Agriculture Organization of the United Nations (FAO) and the World Health Organization (WHO) Lactobacillus ( L. acidophilus , L. casei, L. gasseri, L. delbruekii subsp. Bulgaricus, L. helveticus, L. fermentum, L. paracasei, L. plantarum, L. reuteri, L. rhamnosus and L. salivarius ), one Lactococcus species ( L. lactis ), two Enterococcus species ( E. faecium, E. faecalis ) there are, Streptococcus (Streptococcus) 1 jong (S. thermophilus), Bifidobacterium (Bifidobacterium) 4 jong (B. bifidum, B. breve, B. longum, B. animalis subsp. lactis).
특히, 락토바실러스 플란타룸(Lactobacillus plantarum)은 주로 김치, 피클과 같은 침채류 등에서 분리되어 자연계에서 가장 분포가 넓은 유산균으로서 내산성과 내담즙산성이 강하며, 항산화 및 항염증 효과가 있다고 알려져 있으나, 미세먼지로 인한 피부 손상에 미치는 영향에 대한 연구는 보고된 바 없다.In particular, Lactobacillus plantarum is a lactic acid bacterium having the broadest distribution in nature, separated mainly from kimchi, pickles, and the like, and is known to have strong acid and bile acid resistance and antioxidant and anti-inflammatory effects. However, No studies have been reported on the effects of microdirt on skin damage.
이에 본 발명자들은 락토바실러스 플란타룸(Lactobacillus plantarum) HY7715가 미세먼지로 인한 활성산소 생성을 억제하고, 관련 유전자들의 발현을 조절함으로써 사람의 피부세포의 손상을 방지 및 개선하는 효능을 가진다는 사실을 발견하여 본 발명을 완성하게 되었다.Accordingly, the present inventors have found that Lactobacillus plantarum HY7715 has an effect of inhibiting the generation of active oxygen due to fine dust and controlling the expression of related genes, thereby preventing and improving the damage of human skin cells Thereby completing the present invention.
본 발명은 사람의 피부세포에서 AhR(Aryl hydrocarbon receptor) 및 CYP1A1(Cytochrome P450 1A1) 유전자의 발현을 감소시킴으로써 다환방향족 탄화수소가 포함된 미세먼지로 인한 피부의 손상을 방지 및 개선하는 효능을 갖는 락토바실러스 플란타룸(Lactobacillus plantarum) HY7715을 유효성분으로 함유하는 미세먼지에 의한 피부의 손상 방지 및 개선을 위한 조성물을 제공하는 것을 목적으로 한다.The present invention relates to a pharmaceutical composition for reducing the expression of AhR (Aryl hydrocarbon receptor) and CYP1A1 (Cytochrome P450 1A1) gene in human skin cells, and to provide a method for inhibiting the damage of skin caused by fine dust containing polycyclic aromatic hydrocarbons It is an object of the present invention to provide a composition for preventing and improving skin damage caused by fine dust containing Lactobacillus plantarum HY7715 as an active ingredient.
상기의 목적을 달성하기 위하여, 본 발명은 인체유래의 각질세포(HaCaT)에 다환방향족 탄화수소가 포함된 미세먼지를 처리함으로써 발생하는 피부의 손상과 관련된 AhR(Aryl hydrocarbon receptor) 및 CYP1A1(Cytochrome P450 1A1) 유전자의 발현을 감소시킴으로써 미세먼지에 의한 피부의 손상을 방지 및 개선하는 효능을 갖는 락토바실러스 플란타룸(Lactobacillus plantarum) HY7715을 유효성분으로 함유하는 미세먼지에 의한 피부의 손상 방지 및 개선을 위한 조성물을 제공하는 것을 특징으로 한다.In order to achieve the above object, the present invention relates to a pharmaceutical composition comprising an AhR (Aryl hydrocarbon receptor) and CYP1A1 (Cytochrome P450 1A1) associated with skin damage caused by treating microdirts containing polycyclic aromatic hydrocarbons in human keratinocytes (HaCaT) ) Lactobacillus plantarum HY7715, which has the effect of preventing and improving skin damage caused by fine dusts by reducing the expression of genes, is used as an active ingredient to prevent and improve skin damage caused by fine dusts ≪ / RTI >
이하, 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.
본 발명에 따른 미세먼지는 European Reference Materials에서 제조된 ERM®-CZ100을 사용하였다. 해당 시료는 실제 도로 환경에서 분리된 미세먼지로 PM10 정도의 크기이다. 해당 시료는 Benzo[a]anthracene, Benzo[a]pyrene, Benzo[b]fluoranthene, Benzo[j]fluoranthene, Benzo[k]fluoranthene, Dibenzo[a,h]anthracene, Indeno[1,2,3-c,d]pyrene와 같은 다환방향족 탄화수소를 포함한다.Fine particles according to the invention was used for the ERM ® -CZ100 prepared in European Reference Materials. The sample is PM10, which is fine dust separated from the actual road environment. These samples include Benzo [a] anthracene, Benzo [a] pyrene, Benzo [b] fluoranthene, Benzo [j] fluoranthene, Benzo [k] fluoranthene, Dibenzo [a, h] anthracene, , d] pyrene.
본 발명에 따른 락토바실러스 플란타룸(Lactobacillus plantarum) HY7715를 분리하기 위해 충남 보령, 충남 서천, 전북 고창, 전북 순창, 전남 담양, 전남 고흥, 전남 여수 돌산, 전남 보성, 벌교, 경남 하동의 웅천장, 서천장, 고창장, 고흥장 등 재래시장 내 반찬가게에서 판매자가 갓 제조한 김치 등 발효식품을 수집하여 파쇄 후 거름액을 글리세롤(glycerol)과 혼합하여 균주 분리 전까지 -80℃에서 보관하였다. 상기 수집시료의 글리세롤 스톡(glycerol stock)으로부터 균주를 분리하기 위해 호기성 희석액 900㎕와 발효식품 시료의 글리세롤 스톡(glycerol stock) 100㎕를 혼합하여 연속 희석을 수행하였다. 상기 10-1~10-6 희석 시료 중 플레이트(plate) 당 100㎕를 브롬크레졸퍼플(Bromocresol Puple)이 함유된 MRS-agar 배지에 평판도말하고 37℃에서 48시간 이상 배양하였다. 배양 후 형성된 노란색 미생물 군집(colony)을 멸균 루프로 취하여 동일 배지와 동일 온도 조건에서 3차례 이상 계대배양을 수행함으로써 단일 미생물 군집(single colony)을 확보하였다. 이와 같이 분리된 락토바실러스 플란타룸(Lactobacillus plantarum) HY7715의 균학적 특성을 설명하면 다음과 같다. In order to isolate Lactobacillus plantarum HY7715 according to the present invention, it is necessary to isolate Lactobacillus plantarum HY7715 from Bongryong, Chuncheon, Seochun, Jeonbuk, Chonbuk, Chonnam, Jeonnam, Gohung, Yeosu, Dolsan, Jeonnam, Boseong, , Seochung, Gochang, Goheung, and others. The fermented food such as kimchi prepared by the seller was collected, and the broth was mixed with glycerol and stored at -80 ℃ until the isolate. In order to separate the strain from the glycerol stock of the collected sample, 900 μl of the aerobic diluent and 100 μl of the glycerol stock of the fermented food sample were mixed to perform serial dilution. The 10 -1 to 10 -6 dilution of the sample plate (plate) 100㎕ per Bromcresol Purple (Bromocresol Puple) telling flatness in the MRS-agar medium containing the cells were cultured for 48 hours or more at 37 ℃. A single colony was obtained by subculturing the yellow microorganism colony formed after cultivation by sterilization loop and carrying out subculture three times at the same temperature and at the same temperature condition. The mycological characteristics of Lactobacillus plantarum HY7715 thus isolated are as follows.
1)균의 형태 (MRS 한천평판배지에서 37℃, 2일간 배양했을 때 균의 특성)1) The morphology of bacteria (characteristics of bacteria when cultured on MRS agar plate at 37 ℃ for 2 days)
①세포의 형태: 간균① Cell shape: Bacillus
②운동성: 없음② Mobility: None
③포자형성능: 없음③ Spore forming ability: None
④그람(Gram) 염색: 양성④ Gram staining: positive
2)균락의 형태 (MRS 한천평판배지에서 37℃, 2일간 배양했을 때 균의 특성)2) Morphology of bacteria (characteristics of bacteria when cultured at 37 ℃ for 2 days on MRS agar plate medium)
①형상: 원형① Shape: Circular
②융기: 볼록② Bump: convex
③표면: 매끈(smooth)③ Surface: smooth
3)생리적 성질3) Physiological properties
①생육온도: 생장가능 생육온도 13~43℃, 최적 생장온도 33~37℃① Growth temperature: Growth possible Growth temperature 13 ~ 43 ℃, Optimum growth temperature 33 ~ 37 ℃
②생육 pH: 생장가능 생육 pH 3.5~3.7, 최적 pH 5.0~5.5② Growth pH: Growable growth pH 3.5 ~ 3.7, Optimum pH 5.0 ~ 5.5
③산소에 대한 영향: 통성혐기성③ Effect on oxygen: Tumor anaerobic
④카탈라제: -④ Catalase: -
⑤가스형성여부: -⑤ Whether gas is formed: -
⑥15℃에서 생육: +⑥ Growth at 15 ℃: +
⑦45℃에서 생육: -⑦ Growth at 45 ℃: -
⑧인돌생산: -⑧ Indole production: -
⑨젖산생산: +⑨ Lactic acid production: +
⑩16S rDNA 분석⑩16S rDNA analysis
16S rDNA 분석을 통한 분자유전학적인 방법을 실시하여 본 발명의 균주를 동정하였다. 16S rDNA 염기 서열 분석 결과를 표 1에 나타내었다(http://www.ncbi.nlm.nih.gov/blast). The strain of the present invention was identified by conducting a molecular genetic method through 16S rDNA analysis. The results of 16S rDNA sequencing are shown in Table 1 (http://www.ncbi.nlm.nih.gov/blast).
하기의 표 1에서 확인할 수 있는 바와 같이, 본 발명의 락토바실러스 플란타룸(Lactobacillus plantarum) HY7715의 16S rRNA 유전자는 락토바실러스 플란타룸(Lactobacillus plantarum)의 16S rRNA 유전자와 99% 일치하는 것으로 확인되었다.As can be seen in the following Table 1, the 16S rRNA gene of Lactobacillus plantarum HY7715 of the present invention was found to be 99% identical to the 16S rRNA gene of Lactobacillus plantarum .
identMax
ident
complete genome Lactobacillus plantarum strain HFC8,
complete genome
이상의 16S rRNA 서열 및 균학적 특성에 의해 본 발명의 균주를 락토바실러스 플란타룸(Lactobacillus plantarum) HY7715로 명명하고, 이를 2016년 9월 8일자로 한국생명공학연구원에 기탁하였다(수탁번호: KCTC 13101BP).Based on the above 16S rRNA sequence and mycological characteristics, the strain of the present invention was named Lactobacillus plantarum HY7715 and deposited on August 8, 2016 with the Korea Research Institute of Bioscience and Biotechnology (Accession No .: KCTC 13101BP ).
본 발명의 락토바실러스 플란타룸(Lactobacillus plantarum) HY7715 생균 또는 이의 파쇄물을 유효성분으로 함유하는 식품조성물은 식품, 식품첨가제, 음료, 음료첨가제, 발효유, 건강기능식품 등으로 사용될 수 있다.The food composition containing the Lactobacillus plantarum HY7715 live cell of the present invention or the lysate thereof as an active ingredient can be used as food, food additive, beverage, beverage additive, fermented milk, health functional food, and the like.
특히, 본 발명의 락토바실러스 플란타룸(Lactobacillus plantarum) HY7715 생균 또는 이의 파쇄물을 유효성분으로 함유하는 발효유는 프로바이오틱스의 동결건조분말, 유산균 배양액 및 혼합과즙시럽을 일정비율로 조합하여 150bar에서 균질한 후 10℃ 이하로 냉각한 후 용기에 포장하여 발효유를 제조한다.Particularly, the fermented milk containing the Lactobacillus plantarum HY7715 live bacterium of the present invention or the lysate thereof as an active ingredient is obtained by homogenizing the lyophilized powder of probiotics, the culture liquid of lactic acid bacteria and the mixed fruit syrup at a certain ratio at 150 bar After cooling to below 10 ° C, it is packaged in a container to produce fermented milk.
또한, 본 발명의 락토바실러스 플란타룸(Lactobacillus plantarum) HY7715 생균 또는 이의 파쇄물을 유효성분으로 함유하는 기능성 음료는 혼합과즙시럽, 프로바이오틱스의 동결건조분말 및 물을 일정한 비율로 조합하여 150bar에서 균질한 후 10℃ 이하로 냉각한 후 유리병, 패트병 등 소포장 용기에 포장하여 기능성 음료를 제조한다.The functional beverage containing the Lactobacillus plantarum HY7715 live bacterium of the present invention or the lysate thereof as an active ingredient is prepared by combining the mixed fruit juice syrup, freeze-dried powder of probiotics and water at a constant ratio and homogenizing at 150 bar After cooling to 10 ° C or less, functional beverages are prepared by packaging in small containers such as glass bottles and plastic bottles.
또한, 본 발명의 락토바실러스 플란타룸(Lactobacillus plantarum) HY7715 생균 또는 이의 파쇄물을 유효성분으로 함유하는 건강기능식품은 프로바이오틱스의 동결건조분말을 포함하는 것 이외에 영양보조 성분으로 비타민 B1, B2, B5, B6, E 및 초산에스테르, 니코틴산 아미드, 올리고당 등이 첨가될 수 있으며 여타의 식품 첨가물이 첨가되어도 무방하다.In addition, the health functional food containing the Lactobacillus plantarum HY7715 live bacterium or the lysate thereof as an active ingredient of the present invention contains not only lyophilized powder of probiotics but also vitamins B 1 , B 2 , B 5 , B 6 , E and acetic acid esters, nicotinic acid amides, oligosaccharides and the like may be added, and other food additives may be added.
한편, 본 발명의 락토바실러스 플란타룸(Lactobacillus plantarum) HY7715 생균 또는 이의 파쇄물을 유효성분으로 함유하는 화장료 조성물은 락토바실러스 플란타룸(Lactobacillus plantarum) HY7715 외에 기타 화장료의 제형 또는 사용 목적 등에 맞게 임의로 선정한 물질을 첨가할 수 있다. 예를 들어, 정제수, 유분, 계면활성제, 보습제, 고급 알코올, 증점제, 킬레이트제, 색소, 지방산, 산화방지제, 방부제, 왁스, pH 조절제, 향료 등이 첨가될 수 있다.On the other hand, the cosmetic composition containing the Lactobacillus plantarum HY7715 live bacterium of the present invention or the lysate thereof as an active ingredient may be prepared by mixing Lactobacillus plantarum HY7715 with other cosmetics, Materials can be added. For example, purified water, an oil, a surfactant, a moisturizer, a high alcohol, a thickener, a chelating agent, a pigment, a fatty acid, an antioxidant, an antiseptic, a wax, a pH adjusting agent and a perfume may be added.
또한, 본 발명의 락토바실러스 플란타룸(Lactobacillus plantarum) HY7715 생균 또는 이의 파쇄물을 유효성분으로 함유하는 화장료 조성물의 제형은 특별히 제한되는 바가 없지만, 예를 들면, 영양 크림, 수렴 화장수, 유연 화장수, 로션, 에센스, 영양젤, 마사지 크림, 마스크 팩 등의 제형을 가질 수 있다.Further, the formulation of the cosmetic composition containing the Lactobacillus plantarum HY7715 live bacterium of the present invention or the lysate thereof as an active ingredient is not particularly limited, but for example, nutritional cream, convergent lotion, , Essence, nutritional gel, massage cream, mask pack, and the like.
본 발명의 락토바실러스 플란타룸(Lactobacillus plantarum) HY7715는 AhR(Aryl hydrocarbon receptor) 및 CYP1A1(Cytochrome P450 1A1) 유전자의 발현을 감소시킴으로써 다환방향족 탄화수소가 포함된 미세먼지로 인한 피부의 손상을 방지 및 개선하는 효능을 가지므로 이를 유효성분으로 하는 발효유, 건강기능식품, 기능성 음료 등 식품조성물과 화장료 조성물로 사용될 수 있다.The Lactobacillus plantarum HY7715 of the present invention reduces the expression of AhR (Aryl hydrocarbon receptor) and CYP1A1 (Cytochrome P450 1A1) genes, thereby preventing and improving skin damage due to micro dusts containing polycyclic aromatic hydrocarbons It can be used as a food composition and a cosmetic composition such as fermented milk, health functional food, functional beverage and the like as an effective ingredient.
도 1은 인체유래의 각질세포(HaCaT)에서 본 발명의 락토바실러스 플란타룸(Lactobacillus plantarum) HY7715의 미세먼지에 의한 세포사멸보호 효과를 확인한 그래프이다.
도 2는 인체유래의 각질세포(HaCaT)에서 본 발명의 락토바실러스 플란타룸(Lactobacillus plantarum) HY7715의 미세먼지에 의한 AhR 유전자의 발현을 확인한 그래프이다.
도 3은 인체유래의 각질세포(HaCaT)에서 본 발명의 락토바실러스 플란타룸(Lactobacillus plantarum) HY7715의 미세먼지에 의한 CYP1A1 유전자의 발현을 확인한 그래프이다.FIG. 1 is a graph showing the effect of Lactobacillus plantarum HY7715 according to the present invention on keratinocyte-killing keratinocytes (HaCaT).
FIG. 2 is a graph showing the expression of the AhR gene by fine dust of Lactobacillus plantarum HY7715 of the present invention in human keratinocytes (HaCaT).
FIG. 3 is a graph showing the expression of the CYP1A1 gene by fine dust of Lactobacillus plantarum HY7715 of the present invention in human keratinocytes (HaCaT).
이하, 실시예를 통하여 본 발명을 보다 상세하게 설명한다. 그러나, 다음의 실시예는 본 발명의 범위를 한정하는 것은 아니며, 본 발명의 기술적 사상의 범위 내에서 당업자에 의한 통상적인 변화가 가능하다.Hereinafter, the present invention will be described in more detail with reference to Examples. However, the following embodiments are not intended to limit the scope of the present invention, and ordinary variations by those skilled in the art are possible within the scope of the technical idea of the present invention.
<실시예 1>≪ Example 1 >
락토바실러스 플란타룸(Lactobacillus planta room ( Lactobacillus plantarumLactobacillus plantarum ) HY7715 동결건조분말 제조) HY7715 Freeze-dried powder manufacture
락토바실러스 플란타룸(Lactobacillus plantarum) HY7715를 MRS broth 배지에서 배양한 후, 배양액을 8,000rpm에서 15분 동안 원심분리를 하여 얻은 프로바이오틱스 농축액에 대하여 코팅제 및 동결보호제로써 가압 살균된 10중량%의 탈지분유가 함유된 수용액을 1:1의 중량비율로 혼합한 다음, 영하 70℃에서 6시간 동안 동결 후 동결건조분말을 제조하였다. Lactobacillus plantarum HY7715 was cultured in an MRS broth medium, and then the culture broth was centrifuged at 8,000 rpm for 15 minutes to obtain a probiotic concentrate. The resulting concentrate was coated with 10% by weight of pressurized sterilized milk powder Was mixed in a weight ratio of 1: 1, and then freeze-dried powder was prepared by freezing at -70 ° C for 6 hours.
<실시예 2>≪ Example 2 >
락토바실러스 플란타룸(Lactobacillus planta room ( Lactobacillus plantarumLactobacillus plantarum ) HY7715를 유효성분으로 함유하는 발효유의 제조Production of fermented milk containing HY7715 as an active ingredient
유산균 배양액은 원유 95.36중량%와 탈지분유(또는 혼합분유) 4.6중량%를 교반하여 15℃에서의 비중은 1.0473~1.0475, 적정산도는 0.200~0.220%, pH는 6.55~6.70, 20℃에서의 브릭스(Brix0)는 16.3~16.5% 정도가 되도록 혼합하였다. 혼합 후에 이를 UHT 열처리(135℃에서 2초간 살균)하고 적정온도로 냉각한 뒤, 스트렙토코커스 써모필러스균과 유당분해효소(Valley laboratory, USA)를 각기 0.02중량%씩 첨가하고 6시간 동안 배양하여 BCP배지에서의 총 유산균 수가 1.0 X 109cfu/㎖이상, 적정산도가 0.89~0.91%, pH는 4.55~4.65가 되도록 하여 제조하였다. The lactic acid bacteria culture solution was prepared by stirring 95.36% by weight of crude oil and 4.6% by weight of skimmed milk powder (or mixed powdered milk) and having a specific gravity of 1.0473 to 1.0475 at 15 ° C, a titratable acidity of 0.200 to 0.220%, a pH of 6.55 to 6.70, (Brix 0) was about 16.3 to 16.5%. After mixing, the mixture was heat-treated with UHT (sterilized at 135 ° C. for 2 seconds), cooled to an appropriate temperature, added with 0.02% by weight of Streptococcus thermophilus and Lactolytic enzyme (Valley laboratory, USA) The total number of lactic acid bacteria in the medium was 1.0 X 10 9 cfu / ml or more, the titratable acidity was 0.89 to 0.91%, and the pH was 4.55 to 4.65.
혼합과즙시럽은 액상과당 13중량%, 백설탕 5중량%, 혼합과즙농축액 56Brix0 10.9중량%, 펙틴 1.0중량%, 후레쉬후르츠 믹스 에센스 0.1중량% 및 정제수 70중량%를 35℃에서 교반하여 혼합한 후 UHT 열처리(135℃에서 2초간 살균)한 후 냉각하여 제조하였다. The mixed juice syrup was prepared by mixing 13 wt% of liquid fructose, 5 wt% of white sugar, 10.9 wt% of concentrated juice concentrate 56Brix 0 , 1.0 wt% of pectin, 0.1 wt% of fresh fruit mix essence and 70 wt% of purified water, UHT heat treatment (sterilization at 135 캜 for 2 seconds) and cooling.
상기 유산균 배양액 69.5중량%와 상기 실시예 1의 락토바실러스 플란타룸(Lactobacillus plantarum) HY7715 동결건조분말 0.1중량% 및 상기 혼합과즙시럽 30.4중량%를 조합하여 150bar에서 균질한 후 10℃ 이하로 냉각하여 본 발명의 락토바실러스 플란타룸(Lactobacillus plantarum) HY7715를 유효성분으로 함유하는 발효유를 제조하였다.69.5% by weight of the lactic acid bacteria culture solution, 0.1% by weight of Lactobacillus plantarum HY7715 lyophilized powder of Example 1, and 30.4% by weight of the mixed fruit juice syrup were combined and homogenized at 150 bar, A fermented milk containing Lactobacillus plantarum HY7715 of the present invention as an active ingredient was prepared.
<실시예 3>≪ Example 3 >
락토바실러스 플란타룸(Lactobacillus planta room ( Lactobacillus plantarumLactobacillus plantarum ) HY7715를 유효성분으로 함유하는 기능성 음료의 제조) Preparation of functional beverage containing HY7715 as active ingredient
혼합과즙시럽은 액상과당 13중량%, 백설탕 2.5중량%, 갈색설탕 2.5중량%, 혼합과즙농축액 56Brix0 10.9중량%, 펙틴 1.0중량%, 후레쉬후르츠 믹스 에센스 0.1중량% 및 정제수 70중량%를 35℃에서 교반하여 혼합한 후 UHT열처리(135℃에서 2초간 살균)한 후 냉각하여 제조하였다. 그리고, 상기의 방법으로 제조된 혼합과즙시럽 30.4중량%와 상기 실시예 1의 락토바실러스 플란타룸(Lactobacillus plantarum) HY7715 동결건조분말 0.1중량% 및 나머지 정제수 69.5중량% 조합하여 150bar에서 균질한 후 10℃ 이하로 냉각한 후 이를 유리병, 페트병 등 소포장 용기에 포장하여 본 발명의 락토바실러스 플란타룸(Lactobacillus plantarum) HY7715를 유효성분으로 함유하는 기능성 음료를 제조하였다.Mixing juice syrup was 13% by weight of liquid fructose, white sugar, 2.5% by weight, 2.5% by weight brown sugar, mix juice concentrate 56Brix 0 10.9% by weight of the pectin 1.0% by weight, fresh fruit mix Essence 0.1% by weight and pure water 70 wt% 35 ℃ Followed by UHT heat treatment (sterilization at 135 캜 for 2 seconds), followed by cooling. Then, 30.4% by weight of the mixed juice syrup prepared by the above-mentioned method was combined with 0.1% by weight of the lyophobillus plantarum HY7715 of Example 1 and 69.5% by weight of the remaining purified water, homogenized at 150 bar, C, and then packed in a small-sized container such as a glass bottle or PET bottle to prepare a functional beverage containing Lactobacillus plantarum HY7715 as an active ingredient of the present invention.
<실시예 4><Example 4>
락토바실러스 플란타룸(Lactobacillus planta room ( Lactobacillus plantarumLactobacillus plantarum ) HY7715를 유효성분으로 함유하는 건강기능식품의 제조Production of Health Functional Foods Containing HY7715 as Active Ingredient
상기 실시예 1의 락토바실러스 플란타룸(Lactobacillus plantarum) HY7715 동결건조분말 0.1중량%에 영양보조성분(비타민 B1, B2, B5, B6, E 및 초산에스테르, 니코틴산 아미드) 및 올리고당을 상기의 실시예 1의 락토바실러스 플란타룸(Lactobacillus plantarum) HY7715 동결건조분말 100중량부에 대하여 10중량부가 되도록 첨가하여 고속회전 혼합기에서 혼합하였다. 상기 혼합물에 멸균 정제수 10중량부를 첨가, 혼합하고 직경 1~2mm의 과립상으로 성형하였다. 상기 성형된 과립은 50℃의 진공건조기에서 건조시킨 후 12~14메쉬(mesh)를 통과시켜 균일하게 과립을 제조하였다. 상기와 같이 제조된 과립은 적당량씩 압출 성형되어 정제 또는 분말로 되거나 경질캡슐에 충전되어 경질캡슐제품으로 제조하였다.B vitamins B 1 , B 2 , B 5 , B 6 , E and acetic acid ester, nicotinic acid amide) and oligosaccharides were added to 0.1 wt% of Lactobacillus plantarum HY7715 lyophilized powder of Example 1 Was added in an amount of 10 parts by weight based on 100 parts by weight of the Lactobacillus plantarum HY7715 lyophilized powder of Example 1 and mixed in a high-speed rotary mixer. 10 parts by weight of sterilized purified water was added to the mixture, mixed and molded into granules having a diameter of 1 to 2 mm. The molded granules were dried in a vacuum dryer at 50 ° C and then passed through 12 to 14 mesh to uniformly produce granules. The granules thus prepared were extruded in suitable amounts to be purified or powdered or filled into hard capsules to prepare hard capsule products.
<실시예 5>≪ Example 5 >
락토바실러스 플란타룸(Lactobacillus planta room ( Lactobacillus plantarumLactobacillus plantarum ) HY7715를 유효성분으로 함유하는 화장료 조성물의 제조) Preparation of cosmetic composition containing HY7715 as an active ingredient
영양화장수Nutritional lotion
상기 실시예 1의 락토바실러스 플란타룸(Lactobacillus plantarum) HY7715 동결건조분말 0.01중량%, 밀납 4중량%, 폴리소르베이트 60 1.5중량%, 소르비탄세스퀴올레이트 0.5중량%, 유동파라핀 5중량%, 스쿠알란 5중량%, 카프릴릭/카프릭 트리글리세라이드 5중량%, 글리세린 3중량%, 부틸렌 글리콜 3중량%, 프로필렌 글리콜 3중량%, 카르복시비닐폴리머 0.1중량%, 트리에탄올아민 0.2중량%, 잔량의 방부제, 미량색소, 미량향료 및 미량정제수를 혼합하여 통상의 영양화장수 제조방법에 따라 제조하였다.The liquid preparation was prepared by mixing 0.01 wt% of Lactobacillus plantarum HY7715 lyophilized powder of Example 1, 4 wt% of wax, 1.5 wt% of polysorbate 60, 0.5 wt% of sorbitan sesquioleate, 5 wt% of liquid paraffin, 5% by weight squalane, 5% by weight caprylic / capric triglyceride, 3% by weight glycerin, 3% by weight butylene glycol, 3% by weight propylene glycol, 0.1% by weight carboxyvinyl polymer, 0.2% by weight triethanolamine A preservative, a trace pigment, a trace amount of perfume, and a trace amount of purified water were mixed and prepared according to a conventional nutrition lotion production method.
영양크림Nourishing cream
상기 실시예 1의 락토바실러스 플란타룸(Lactobacillus plantarum) HY7715 동결건조분말 0.01중량%, 밀납 10중량%, 폴리소르베이트 60 1.5중량%, 소르비탄세스퀴올레이트 0.5중량%, 유동파라핀 10중량%, 스쿠알란 5중량%, 카프릴릭/카프릭 트리글리세라이드 5중량%, 글리세린 5중량%, 부틸렌 글리콜 3중량%, 프로필렌 글리콜 3중량%, 트리에탄올아민 0.2중량%, 잔량의 방부제, 미량색소, 미량향료 및 미량정제수를 혼합하여 통상의 영양크림 제조방법에 따라 제조하였다., 0.01 wt% of Lactobacillus plantarum HY7715 lyophilized powder of Example 1, 10 wt% of wax, 1.5 wt% of polysorbate 60, 0.5 wt% of sorbitan sesquioleate, 10 wt% of liquid paraffin, 5 parts by weight of squalane, 5 parts by weight of caprylic / capric triglyceride, 5 parts by weight of glycerin, 3 parts by weight of butylene glycol, 3 parts by weight of propylene glycol, 0.2 part by weight of triethanolamine, the remaining preservative, And a trace amount of purified water were mixed and prepared according to a conventional nutrition cream preparation method.
맛사지크림Massage Cream
상기 실시예 1의 락토바실러스 플란타룸(Lactobacillus plantarum) HY7715 동결건조분말 0.01중량%, 밀납 10중량%, 폴리소르베이트 60 1.5중량%, 소르비탄세스퀴올레이트 0.8중량%, 유동파라핀 40중량%, 스쿠알란 5중량%, 카프릴릭/카프릭 트리글리세라이드 4중량%, 글리세린 5중량%, 부틸렌 글리콜 3중량%, 프로필렌 글리콜 3중량%, 트리에탄올아민 0.2중량%, 잔량의 방부제, 미량색소, 미량향료 및 미량정제수를 혼합하여 통상의 맛사지크림 제조방법에 따라 제조하였다.( Lactobacillus plantarum HY7715 lyophilized powder of Example 1, 0.01 wt% of wax, 10 wt% of wax, 1.5 wt% of polysorbate 60, 0.8 wt% of sorbitan sesquioleate, 40 wt% of liquid paraffin, 5% by weight squalane, 4% by weight caprylic / capric triglyceride, 5% by weight glycerin, 3% by weight butylene glycol, 3% by weight propylene glycol, 0.2% by weight triethanolamine, remaining preservatives, And a trace amount of purified water were mixed to prepare a conventional massage cream.
팩pack
상기 실시예 1의 락토바실러스 플란타룸(Lactobacillus plantarum) HY7715 동결건조분말 0.01중량%, 폴리비닐알콜 13중량%, 소듐카복시메틸셀룰로스 0.2중량%, 알란토인 0.1중량%, 에탄올 5중량%, 노닐페닐에테르 0.3중량%, 잔량의 방부제, 미량색소, 미량향료 및 미량정제수를 혼합하여 통상의 팩 제조방법에 따라 제조하였다., 0.01 wt% of Lactobacillus plantarum HY7715 lyophilized powder of Example 1, 13 wt% of polyvinyl alcohol, 0.2 wt% of sodium carboxymethyl cellulose, 0.1 wt% of allantoin, 5 wt% of ethanol, 0.3% by weight, the remaining preservative, trace pigment, trace flavor and trace amount of purified water were mixed and prepared according to a conventional pack preparation method.
<시험예 1>≪ Test Example 1 >
1-1. 락토바실러스 플란타룸( Lactobacillus plantarum ) HY7715 생균체의 제조 1-1. Lactobacillus Planta Room (Lactobacillus plantarum) manufacture of raw HY7715 cells
락토바실러스 플란타룸(Lactobacillus plantarum) HY7715를 MRS 액체배지에 접종하여 37℃에서 18~20시간 배양하였다. 정확한 생균수를 확인하기 위해 배양이 완료된 상기 유산균을 십진 희석하여 MRS agar 배지를 이용하여 37℃에서 2~3일간 배양해 균수를 측정하였다. Lactobacillus plantarum HY7715 was inoculated into the MRS liquid medium and cultured at 37 占 폚 for 18 to 20 hours. To confirm the number of viable bacteria, the cultured lactic acid bacterium was subjected to decidual dilution and cultured at 37 ° C. for 2 to 3 days using MRS agar medium to measure the number of bacteria.
세포 실험에 적용 시 앞서 구한 균수를 기준으로 하여 세포 배양에 사용한 배지를 넣고 희석해 생균체로 사용하였다.When applied to cell experiments, the medium used for cell culture was added based on the previously obtained number of cells, and the cells were diluted and used as live cells.
1-2. 인체유래 각질세포(HaCaT) 세포의 배양 1-2. Culture of human keratinocyte (HaCaT) cells
10% FBS(fetal bovine serum)와 1% 항생제를 포함한 DMEM 배지(Gibco, USA)에서 인체유래 각질세포(HaCaT)와 DMEM을 1:4의 중량비율로 2~3일에 한 번씩 계대 배양하여 사용하였다(배양 조건: 5% CO2가 공급되는 37℃ 배양기). Human corneal keratinocytes (HaCaT) and DMEM were subcultured in a 1: 4 weight ratio once every 2-3 days in DMEM medium (Gibco, USA) containing 10% fetal bovine serum and 1% (Culture conditions: 37 ° C incubator supplied with 5% CO 2 ).
즉, 계대를 위하여 DMEM 배지를 제거하고 PBS 4㎖로 1회 세척한 후, Trypsin-EDTA Solution 1X(1XTE, Sigma)를 1㎖ 처리하여 배양기에 10~15분 동안 넣어두었다. 인체유래 각질세포(HaCaT)의 부착이 떨어진 것을 확인한 후 DMEM 배지 4㎖를 넣어 인체유래 각질세포(HaCaT)를 회수하였다. 상기 회수된 인체유래 각질세포(HaCaT)를 1,200rpm으로 3분 동안 원심분리를 한 후, 상등액을 조심스럽게 제거하고, DMEM 배지 1㎖를 넣어 세포 펠렛을 풀어 주었다. 인체유래 각질세포(HaCaT)와 DMEM 배지를 1:4의 중량비율로 희석한 후 100Ø 세포배양접시에 넣고 잘 혼합한 후 배양기에서 2~3일간 배양하여 사용하였다.In other words, for the passage, the DMEM medium was removed, washed once with 4 ml of PBS, treated with 1 ml of Trypsin-EDTA Solution 1X (1XTE, Sigma), and placed in the incubator for 10 to 15 minutes. After confirming that the adhesion of keratinocytes (HaCaT) from the human body was deteriorated, 4 ml of DMEM medium was added to recover keratinocytes (HaCaT) from the human body. The recovered human keratinocyte (HaCaT) was centrifuged at 1,200 rpm for 3 minutes, the supernatant was carefully removed, and 1 ml of DMEM medium was added to dissolve the cell pellet. Human keratinocytes (HaCaT) and DMEM medium were diluted in a weight ratio of 1: 4, put into a 100Ø cell culture dish, mixed well and incubated for 2-3 days in an incubator.
1-3. 락토바실러스 플란타룸( Lactobacillus plantarum ) HY7715의 세포사멸보호 효과 1-3. Lactobacillus Planta Room (Lactobacillus plantarum) apoptosis protective effect HY7715
상기 시험예 1-2의 인체유래 각질세포(HaCaT)를 96웰(well)에 웰(well)당 2x104cells로 접종한 후, 24~48시간 동안 배양한 후, FBS가 들어가지 않은 DMEM 배지로 1회 세척하여 주었다.Human keratinocytes (HaCaT) of Test Example 1-2 were inoculated in 96 wells at 2 × 10 4 cells per well and cultured for 24 to 48 hours. Then, DMEM medium without FBS . ≪ / RTI >
FBS가 들어가지 않은 DMEM 배지에 상기 시험예 1-1의 락토바실러스 플란타룸 (Lactobacillus plantarum) HY7715 생균체를 1x107CFU/㎖의 농도로 용해하여 상기 FBS가 들어가지 않은 DMEM 배지로 1회 세척된 각 웰의 인체유래 각질세포(HaCaT)에 처리하였고, 이와 동시에 다환방향족탄화수소가 포함된 미세먼지인 ERM®-CZ100(European Reference Materials, Sigma)을 250μg/㎖의 농도로 상기 각 웰의 인체유래 각질세포(HaCaT)에 처리하였다. Lactobacillus plantarum HY7715 cells of Test Example 1-1 were dissolved at a concentration of 1 × 10 7 CFU / ml in a DMEM medium not containing FBS, and the cells were washed once with DMEM without FBS (HaCaT) of each well, and at the same time, ERM ® -CZ100 (European Reference Materials, Sigma), which is a fine dust containing polycyclic aromatic hydrocarbons, was treated at a concentration of 250 μg / Keratinocytes (HaCaT).
그런다음, 상기 락토바실러스 플란타룸(Lactobacillus plantarum) HY7715 생균체와 미세먼지가 처리된 인체유래 각질세포(HaCaT)를 20~24시간 동안 배양한 후 CCK-8 assay 용액을 각 웰당 10㎕ 처리하고, 1~4시간 후 분광광도계를 이용하여 540nm에서 흡광도를 측정하여 세포생존율을 계산하였다.Then, the above-mentioned Lactobacillus plantarum HY7715 and microparticles-treated human keratinocytes (HaCaT) were cultured for 20 to 24 hours, and 10 μl of each CCK-8 assay solution was treated , And the cell viability was calculated by measuring the absorbance at 540 nm using a spectrophotometer after 1 to 4 hours.
한편, 음성대조군으로는 인체유래 각질세포(HaCaT)에 아무것도 처리하지 않은 것을 제외하고는 상기와 동일한 방법으로 시험하였다.On the other hand, as the negative control group, the test was carried out in the same manner as above except that the human keratinocyte (HaCaT) was not treated.
또한, 양성대조군으로는 인체유래 각질세포(HaCaT)에 상기 미세먼지 만을 처리한 것을 제외하고는 상기와 동일한 방법으로 시험하였다.As a positive control, the test was carried out in the same manner as above except that the human keratinocyte (HaCaT) was treated with only the fine dust.
여기서, '세포생존율'은 시험 진행 후 미세먼지 및 유산균 처리시의 흡광도를 시험 진행 후 음성대조군의 흡광도로 나눈 값의 백분율을 의미한다.Here, 'cell survival rate' means the percentage of the absorbance of the fine dust and the lactic acid bacteria treated after the test divided by the absorbance of the negative control group after the test.
그 결과를 도 1에 나타내었다.The results are shown in Fig.
도 1에서 확인할 수 있는 바와 같이, 음성대조군의 세포 생존율 100%를 기준으로 미세먼지 만을 처리한 양성대조군의 경우에는 세포 생존율이 68.1%로 감소하였으나, 미세먼지와 락토바실러스 플란타룸(Lactobacillus plantarum) HY7715를 동시에 처리한 실험군(HY7715)의 경우에는 세포 생존율이 96.6% 까지 증가하였음을 확인할 수 있었다. 이러한 사실을 통하여 본 발명의 락토바실러스 플란타룸(Lactobacillus plantarum) HY7715는 미세먼지 처리에 따른 세포의 사멸을 억제하는 효과를 가진다는 것을 알 수 있다.As can be seen from FIG. 1, the cell viability was reduced to 68.1% in the positive control group treated with only the fine dust on the basis of the cell viability of 100% of the negative control group, but the microorganism , Lactobacillus plantarum , In the case of HY7715 treated group (HY7715), cell viability increased up to 96.6%. From these facts, it can be seen that Lactobacillus plantarum HY7715 of the present invention has an effect of inhibiting cell death due to fine dust treatment.
<시험예 2>≪ Test Example 2 &
2-1. 미세먼지가 처리된 인체유래 각질세포(HaCaT)에서의 RNA 추출 2-1. Extraction of RNA from human-derived keratinocytes (HaCaT) treated with fine dusts
상기 시험예 1-2의 인체유래 각질세포(HaCaT)를 96웰에 웰당 2x104cells로 접종한 후, 24~48시간 동안 배양한 후, FBS가 들어가지 않은 DMEM 배지로 1회 세척하여 주었다.The human keratinocytes (HaCaT) of Test Example 1-2 were inoculated in 96 wells at 2 × 10 4 cells / well, cultured for 24 to 48 hours, and washed once with DMEM medium containing no FBS.
FBS가 들어가지 않은 DMEM 배지에 상기 시험예 1-1의 락토바실러스 플란타룸(Lactobacillus plantarum) HY7715 생균체를 1x107CFU/㎖의 농도로 용해하여 상기 FBS가 들어가지 않은 DMEM 배지로 1회 세척된 각 웰의 인체유래 각질세포(HaCaT)에 처리하였고, 이와 동시에 다환방향족 탄화수소가 포함된 미세먼지인 ERM®-CZ100(European Reference Materials, Sigma)를 50μg/㎖의 농도로 상기 각 웰의 인체유래 각질세포(HaCaT)에 처리하였다. Lactobacillus plantarum HY7715 cells of Test Example 1-1 were dissolved at a concentration of 1 × 10 7 CFU / ml in a DMEM medium not containing FBS, and the cells were washed once with DMEM without FBS was treated in the human-derived keratinocytes (HaCaT) of each well at the same time the human origin of the fine particles for each well of ERM ® -CZ100 (European Reference Materials, Sigma) containing the polycyclic aromatic hydrocarbon in a concentration of 50μg / ㎖ Keratinocytes (HaCaT).
그런 다음, 상기 락토바실러스 플란타룸(Lactobacillus plantarum) HY7715 생균체와 미세먼지가 처리된 인체유래 각질세포(HaCaT)를 20~24시간 동안 배양한 후, PBS로 2번 세척해 준 후 easy-spin™ lysis buffer(iNtRON, USA) 1㎖를 넣고 상기 인체유래 각질세포(HaCaT)를 용해하였다. 상기 용해된 인체유래 각질세포(HaCaT)에서 easy-spin™ [DNA free] Total RNA Extraction Kit(Invitrogen, USA)를 사용하여 RNA를 추출하였다. RNA 순도와 분해정도는 ND-1000 Spectrophotometer(NanoDrop, Wilmington, USA)와 Agilent 2100 Bioanalyzer(Agilent Technologies, Palo Alto, USA)으로 확인하였다.Then, the Lactobacillus plantarum HY7715 and microdermabrasion-treated keratinocytes (HaCaT) were cultured for 20 to 24 hours, washed twice with PBS, and then treated with an easy-spin ™ into a lysis buffer (iNtRON, USA) 1㎖ it was dissolved in the human body-derived keratinocyte (HaCaT). RNA was extracted from the dissociated human keratinocytes (HaCaT) using the easy-spin ™ [DNA free] Total RNA Extraction Kit (Invitrogen, USA). RNA purity and degree of degradation were confirmed by ND-1000 Spectrophotometer (NanoDrop, Wilmington, USA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, USA).
한편, 유전자 발현 변화의 원인을 보다 명확히 하기 위하여 상기 시험예 1-1의 락토바실러스 플란타룸(Lactobacillus plantarum) HY7715 생균체 만을 처리한 것을 제외하고 상기와 동일한 방법으로 RNA를 추출하였다.On the other hand, in order to clarify the cause of gene expression change, RNA was extracted in the same manner as above except that only the Lactobacillus plantarum HY7715 cells of Test Example 1-1 were treated.
또한, 유전자 발현 변화의 원인을 보다 명확히 하기 위하여 양성대조군으로는 미세먼지 만을 처리한 것을 제외하고 상기와 동일한 방법으로 RNA를 추출하였다.In order to clarify the cause of gene expression change, RNA was extracted in the same manner as above except that only fine dust was treated as a positive control.
또한, 유전자 발현 변화의 원인을 보다 명확히 하기 위하여 음성대조군으로는 인체유래 각질세포(HaCaT)에 아무것도 처리하지 않은 것을 제외하고 상기와 동일한 방법으로 RNA를 추출하였다.In order to further clarify the cause of the gene expression change, RNA was extracted in the same manner as above except that no negative treatment was carried out on human keratinocytes (HaCaT) as a negative control group.
2-2. 실시간 중합효소 연쇄반응을 이용한 미세먼지가 처리된 인체유래 각질세포(HaCaT)에서의 유전자 발현 분석 2-2. Analysis of Gene Expression in Human Dermal Keratinocyte (HaCaT) Treated with Real Time Polymerase Chain Reaction
락토바실러스 플란타룸(Lactobacillus plantarum) HY7715가 미세먼지에 대해 세포사멸을 보호하는 효과를 보여 이를 설명하기 위해 외부물질에 대한 인식 및 독성 조정에 관련있는 CYP1A1(Cytochrome P450 1A1)과 이에 대한 상위 인자인 AhR (Aryl hydrocarbon receptor) 유전자 발현을 분석하였다. Lactobacillus plantarum HY7715 was shown to protect against apoptosis. To explain this, we compared CYP1A1 (Cytochrome P450 1A1), which is involved in recognition and toxicity of foreign substances, AhR (Aryl hydrocarbon receptor) gene expression was analyzed.
즉, 락토바실러스 플란타룸(Lactobacillus plantarum) HY7715 생균체 만을 처리한 경우를 제외한 상기 시험예 2-1의 분리한 각각의 RNA로부터 Omniscript reverse transcription kit(Qiagen, Germany)를 사용하여 cDNA를 합성하였다. RNA 발현은 Taqman gene expression master mix(Taqman, USA)를 이용하였고, QuantStudio 6 Flex Real-Time PCR System(Applied biosystems, USA)으로 분석 및 정량하였다. 이를 위해 사용한 인간유래 프라이머(primer)는 GAPDH(Hs03929097_g1), CYP1A1(Hs01054796_g1), AHR(Hs00169233_m1)으로 Tagman사를 통해 주문하여 사용하였다. 유전자 발현의 지표인 Ct(treshhold cycle)를 바탕으로 유전자 발현의 배수차이(fold change)를 계산하였다.Namely, cDNAs were synthesized from each of the separated RNAs of Test Example 2-1 except that only Lactobacillus plantarum HY7715 cells were treated with the Omniscript reverse transcription kit (Qiagen, Germany). RNA was expressed and quantified using QuantStudio 6 Flex Real-Time PCR System (Applied Biosystems, USA) using Taqman gene expression master mix (Taqman, USA). Human primers used for this purpose were ordered through Tagman as GAPDH (Hs03929097_g1), CYP1A1 (Hs01054796_g1) and AHR (Hs00169233_m1). Fold change in gene expression was calculated based on the Ct (treshhold cycle), an index of gene expression.
그 결과를 도 2(AhR 유전자 발현) 및 도 3(CYP1A1 유전자 발현)에 나타내었다.The results are shown in Fig. 2 (AhR gene expression) and Fig. 3 (CYP1A1 gene expression).
도 2에서 확인할 수 있는 바와 같이, 인체유래 각질세포(HaCaT)에 아무것도 처리하지 않은 음성대조군의 유전자 발현 1을 기준으로, 미세먼지 만을 처리한 양성대조군에서는 AhR(Aryl hydrocarbon receptor)의 유전자 발현이 5.2배 증가하였으나, 미세먼지와 락토바실러스 플란타룸(Lactobacillus plantarum) HY7715 생균체를 동시에 처리한 실험군(HY7715)에서는 AhR(Aryl hydrocarbon receptor)의 유전자 발현이 2.3배로 감소하였다.As can be seen from Fig. 2, the gene expression of AhR (Aryl hydrocarbon receptor) in the positive control treated with only fine dust was 5.2 (based on the gene expression 1 of the negative control not treated with keratinocytes (HaCaT) However, the gene expression of AhR (Aryl hydrocarbon receptor) decreased 2.3 times in the experimental group (HY7715) treated with micro dust and Lactobacillus plantarum HY7715 cells simultaneously.
도 3에서 확인할 수 있는 바와 같이, 인체유래 각질세포(HaCaT)에 아무것도 처리하지 않은 음성대조군의 유전자 발현 1을 기존으로, 미세먼지 만을 처리한 양성대조군에서는 CYP1A1(Cytochrome P450 1A1) 유전자 발현이 57.3배 증가하였으나, 미세먼지와 락토바실러스 플란타룸(Lactobacillus plantarum) HY7715 생균체를 동시에 처리한 실험군(HY7715)에서는 CYP1A1(Cytochrome P450 1A1)의 유전자 발현이 11.1배로 감소하였다.As can be seen from FIG. 3, gene expression 1 of the negative control group treated with nothing in human keratinocyte (HaCaT) was compared with that of CYP1A1 (Cytochrome P450 1A1) gene in the positive control group treated with only fine dust, However, the expression of CYP1A1 (Cytochrome P450 1A1) decreased to 11.1 fold in the experimental group (HY7715) treated with micro dust and Lactobacillus plantarum HY7715 cells simultaneously.
이상의 도 2와 도 3의 실험결과를 종합하여 보면, 본 발명의 락토바실러스 플란타룸(Lactobacillus plantarum) HY7715은 외부 물질에 대한 인식 및 독성 관련 유전자인 AhR(Aryl hydrocarbon receptor)와 CYP1A1(Cytochrome P450 1A1) 유전자의 발현을 조절함으로써 미세먼지에 대한 보호 효능을 가지고 있음을 확인할 수 있었다.2 and FIG. 3, the Lactobacillus plantarum HY7715 of the present invention contains an AhR (Aryl hydrocarbon receptor) and CYP1A1 (Cytochrome P450 1A1 ) Gene expression, it was confirmed that it has a protective effect against fine dust.
Claims (8)
Lactobacillus plantarum HY7715 (accession number: KCTC 13101BP), which has the effect of preventing the skin damage due to fine dust by reducing the expression of AhR (Aryl hydrocarbon receptor) gene in human skin cells, As an active ingredient to prevent damage to the skin caused by fine dust.
Lactobacillus plantarum HY7715 (accession number: KCTC 13101BP), which has the effect of preventing and improving damage of skin caused by fine dusts by decreasing the expression of CYP1A1 (Cytochrome P450 1A1) gene in human skin cells, As an active ingredient to prevent damage to the skin caused by fine dust.
상기 식품조성물은 발효유, 건강기능식품, 기능성 음료 중에서 선택된 어느 하나의 제형을 갖는 것을 특징으로 하는 식품조성물.
The method according to claim 2 or 3,
Wherein the food composition has one of the formulations selected from the group consisting of fermented milk, health functional food, and functional beverage.
Lactobacillus plantarum HY7715 (accession number: KCTC 13101BP), which has the effect of preventing the skin damage due to fine dust by reducing the expression of AhR (Aryl hydrocarbon receptor) gene in human skin cells, As an active ingredient, to prevent or reduce damage to the skin caused by fine dust.
Lactobacillus plantarum HY7715 (accession number: KCTC 13101BP), which has the effect of preventing and improving damage of skin caused by fine dusts by decreasing the expression of CYP1A1 (Cytochrome P450 1A1) gene in human skin cells, As an active ingredient, to prevent or reduce damage to the skin caused by fine dust.
상기 화장료 조성물은 영양 화장수, 영양 크림, 맛사지 크림 및 팩 중에서 선택된 어느 하나의 제형을 갖는 것을 특징으로 하는 화장료 조성물.The method according to claim 6 or 7,
Wherein the cosmetic composition has one of the formulations selected from a nutritional lotion, a nutritional cream, a massage cream, and a pack.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020180134379A KR101979761B1 (en) | 2018-11-05 | 2018-11-05 | Composition containing Lactobacillus plantarum HY7715 for preventing from skin damage and improving skin health against fine dust as effective component |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020180134379A KR101979761B1 (en) | 2018-11-05 | 2018-11-05 | Composition containing Lactobacillus plantarum HY7715 for preventing from skin damage and improving skin health against fine dust as effective component |
Publications (1)
Publication Number | Publication Date |
---|---|
KR101979761B1 true KR101979761B1 (en) | 2019-05-17 |
Family
ID=66678350
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020180134379A KR101979761B1 (en) | 2018-11-05 | 2018-11-05 | Composition containing Lactobacillus plantarum HY7715 for preventing from skin damage and improving skin health against fine dust as effective component |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101979761B1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102291775B1 (en) * | 2021-01-21 | 2021-08-24 | 주식회사 에치와이 | A food composition comprising mixed fermentation medium |
KR20210115310A (en) * | 2020-03-12 | 2021-09-27 | 주식회사 팜스킨 | Skin protection composition for protecting skin from cytotoxicity caused by fine dust |
KR20220125966A (en) * | 2021-03-08 | 2022-09-15 | 주식회사 에치와이 | Composition for Preventing or Aemliorating Muscular Diseases Comprising Lactobacillus Plantarum HY7715 |
CN116083315A (en) * | 2023-01-17 | 2023-05-09 | 江南大学 | Lactobacillus plantarum CCFM1296 with regulated and controlled host HA content and progeny thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20100059042A (en) * | 2008-11-25 | 2010-06-04 | (주)아모레퍼시픽 | Skin irritation factor with yellow sands, and the methods for inducing the skin irritation and screening the material of inhibiting the skin irritation factor, alleviating the skin irritation in the keratinocyte, and the composition for skin external application containing the material screened by the method |
KR20140128674A (en) * | 2013-04-29 | 2014-11-06 | 주식회사한국야쿠르트 | Probiotics of Lactobacillus plantarum HY7714 for skin wrinkle inhibitory and moisurizing effects and use of thereof as skin anti-wrinkle or moisturizing products |
KR20170059615A (en) | 2015-11-23 | 2017-05-31 | 코웨이 주식회사 | Cosmetic composition for the protection skin damage by air pollutants |
-
2018
- 2018-11-05 KR KR1020180134379A patent/KR101979761B1/en active IP Right Grant
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20100059042A (en) * | 2008-11-25 | 2010-06-04 | (주)아모레퍼시픽 | Skin irritation factor with yellow sands, and the methods for inducing the skin irritation and screening the material of inhibiting the skin irritation factor, alleviating the skin irritation in the keratinocyte, and the composition for skin external application containing the material screened by the method |
KR20140128674A (en) * | 2013-04-29 | 2014-11-06 | 주식회사한국야쿠르트 | Probiotics of Lactobacillus plantarum HY7714 for skin wrinkle inhibitory and moisurizing effects and use of thereof as skin anti-wrinkle or moisturizing products |
KR20170059615A (en) | 2015-11-23 | 2017-05-31 | 코웨이 주식회사 | Cosmetic composition for the protection skin damage by air pollutants |
Non-Patent Citations (3)
Title |
---|
Andrea vierkotter 외, Airborne Particle Exposure and Extrinsic Skin Aging, The Society for Investigative Dermatology, 2719-2726페이지, 2010년.* * |
J.Microbiol.Biotechnol.(2015), 25(1), 74-80. * |
인터넷 신문기사(‘[헬스 동아]"락토바실러스 유산균, 미세먼지 독성 낮춘다.", http://news.donga.com, 2018.04.25.) * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20210115310A (en) * | 2020-03-12 | 2021-09-27 | 주식회사 팜스킨 | Skin protection composition for protecting skin from cytotoxicity caused by fine dust |
KR102366276B1 (en) * | 2020-03-12 | 2022-02-23 | 주식회사 팜스킨 | Skin protection composition for protecting skin from cytotoxicity caused by fine dust |
KR102291775B1 (en) * | 2021-01-21 | 2021-08-24 | 주식회사 에치와이 | A food composition comprising mixed fermentation medium |
KR20220125966A (en) * | 2021-03-08 | 2022-09-15 | 주식회사 에치와이 | Composition for Preventing or Aemliorating Muscular Diseases Comprising Lactobacillus Plantarum HY7715 |
KR102651910B1 (en) | 2021-03-08 | 2024-03-27 | 주식회사 에치와이 | Composition for Preventing or Aemliorating Muscular Diseases Comprising Lactobacillus Plantarum HY7715 |
CN116083315A (en) * | 2023-01-17 | 2023-05-09 | 江南大学 | Lactobacillus plantarum CCFM1296 with regulated and controlled host HA content and progeny thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101979761B1 (en) | Composition containing Lactobacillus plantarum HY7715 for preventing from skin damage and improving skin health against fine dust as effective component | |
CA2721704C (en) | Novel strain of lactobacillus paracasei subspecies paracasei having antimicrobial and immunomodulatory properties | |
KR101958686B1 (en) | Composition containing Bifidobacteirum animalis ssp. lactis HY8002 for preventing from skin damage and improving skin health against fine dust | |
TWI465565B (en) | Fermentated foods containing bacteria of the genus bifidobacterium and method of preparing the same | |
KR102047459B1 (en) | Lactobacillus plantarum WiKim0088 | |
KR100686557B1 (en) | Lactobacillus rhamnosus with body-fat reducing activity and the foods containing them | |
EP2270133B1 (en) | Method for obtaining a novel strain of bifidobacterium bifidum with activity against infection by helicobacter pylori | |
MX2013014340A (en) | Spray-dried lactobacillus stems / cells and the use of same against helicobacter pylori. | |
TWI777107B (en) | Composition with anti-oxidation strains or postbiotics of lactic acid bacterium and uses thereof | |
KR20120111608A (en) | The new lactobacillus plantarum hy7712 stimulate immunity and products containing thereof as effective component | |
EP1790715A1 (en) | Method for stabilizing the antiallergic activity of lactic acid bacteria aganst high-temperature treatment, stabilized compositions, and food and drink | |
TWI689585B (en) | Novel lactic acid strain and immune activating agent containing novel lactic acid strain | |
KR20090116051A (en) | Lactobacillus brevis hy7401 having protective effect against colitis and products containing thereof as effective component | |
EP4241778A1 (en) | Muscle atrophy prevention agent | |
Vitheejongjaroen et al. | Antioxidant activity of Bifidobacterium animalis MSMC83 and its application in set-style probiotic yoghurt | |
JP6110240B2 (en) | Lactic acid bacteria, etc., and oral disease prevention materials and foods containing these | |
KR101969420B1 (en) | Composition for improving oxidative stress and skin moisturizing due to the fine dust and ultraviolet rays containing Lactobacillus casei HY2782 as effective component | |
KR20200145941A (en) | A food composition for prevention or improvement of diseases related to tight junction protein comprising Lactobacillus casei HY2782 as an effective compotent | |
KR101312377B1 (en) | Lactobacillus johnsonii HY7041 having anti-inflammatory functions and products containing thereof as effective component | |
KR20060108964A (en) | Enterococcus faecalis cbt-sl(5), preparation of its culture fluid and composition comprising the same | |
US20230201280A1 (en) | Methods for improving gastrointestinal barrier function and inhibiting growth of enteric pathogenic bacteria | |
KR20130105309A (en) | Cytoprotective agent | |
US20220370522A1 (en) | Lactobacillus amylovorus lam1345 isolate, composition including the same and use thereof | |
KR102049970B1 (en) | Composition for improving oxidative stress due to the fine dust containing Lactobacillus casei HY2782 as effective component | |
Adelekan et al. | Antioxidant activities of exopolysaccharides produced by lactic acid bacteria isolated from commercial yoghurt samples |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |